Juno Therapeutics Gmbh

Samriti Bedi

Stephen Jacob Goldfless

Brian J Belmont

Rupesh Amin

Collin Hauskins

Yue Jiang

Aye Chen

Yeonjoo Oh

Jenna Bailey

Madeline Williams

Andreia Costa

Eric Jeffery

Catherine Sierra

Provided are receptor tyrosine kinase-like orphan receptor 1 (ROR1)-binding molecules, in particular, to human antibodies specific for ROR1, including antibody fragments. The present disclosure further relates to recombinant receptors, including chimeric antigen receptors (CARs) that contain such antibodies or fragments, and polynucleotides that encode the antibodies, antigen-binding fragments or receptors specific for ROR1. The disclosure further relates to genetically engineered cells, containing such ROR1-binding proteins and receptors, and related methods and uses thereof in adoptive cell therapy.

Antibodies and chimeric antigen receptors specific for receptor tyrosine kinase like orphan receptor 1 (ROR1)

Growing community of inventors

Newcastle, WA, United States of America

Samriti Bedi